Hold fast to dreams, ZJU's Class of 2022!2022-06-27Zhejiang University held the commencement and degree conferral ceremony for the Class of 2022 on the morning of June 25. More than 6,000 undergraduates successfully completed their studies and will embark on their next brilliant journey to different destinations all over the world.On behalf of the University, President WU Zhaohui extended his hearty congratulations and best wishes to the graduates... READ MORE |
Zhejiang University and Politecnico di Milano ink MoU online2022-06-22On June 20, Prof. HE Lianzhen, vice president of Zhejiang University, and Prof. Giuliano Noci, vice rector of the Politecnico di Milano(Polimi), signed a university-level MoU via video conferencing.Vice President He reviewed the fruitful cooperation developed between the two institutions in teaching, research and innovative design since 2012 when the first university-level agreement was signed. “... READ MORE |
ZJU scientists discover the mechanism for EC-induced toxicity in fermented food2022-06-16Ethyl carbamate (EC) is a hazardous substance naturally produced during the fermentation of food and beverages. It has been categorized as probably carcinogenic to humans (Group 2A) by the World Health Organization’s International Agency for Research on Cancer (IARC). However, fermented food, such as kimchi, fermented tofu, yellow wine and brandy, is very popular among consumers for its distincti... READ MORE |
ZJU professor helps return a beached whale2022-06-16A male sperm whale was rescued on the shores of Xiangshan county in Ningbo, Zhejiang province, after being beached during low tide for over 20 hours on April 19. Prof. DI Yanan of Ocean College in Zhejiang University participated in the rescue and sent the whale back to surf together with other experts and rescuers.The stranded whale was first noticed in the early morning by a fisherman ... READ MORE |
2nd Sino-German Forum concludes, green building a key focus2022-06-16This year marks the 50th anniversary of the China-Germany diplomatic ties. As one of the important events in the Sustainability Action Plan: A Global ZJU for Social Good, also called “Z4G” for short, the 2nd Sino-German Sustainable Development Forum was successfully held online on June 10. Themed on “Empower SDGs with Green Building”, the forum brought together 30 distinguished scholars from C... READ MORE |
New mechanism in CD47 blockade treatment in HCC2022-06-15China has the highest morbidity of hepatocellular carcinoma (HCC) in the world. For HCC patients in early stage disease, surgical resection is the best treatment strategy, but most patients in advanced stages lose the opportunity for surgery. Due to the limitations of the current targeted drugs Sorafenib and Regorafenib, immune brake point drugs provide a potential treatment for patients in advanc... READ MORE |
Research collaboration between SAHZU and Mass General Brigham kicks off2022-06-15On May 26, 2500 doctors from the Second Affiliated Hospital, Zhejiang University School of Medicine (SAHZU) attended an educational and informative lecture about clinical study design delivered by Dr. James Megis, Professor of Medicine at Harvard Medical School and Co-Director of the MGH Clinical Research Program’s Clinical Effectiveness Research GroupThe lecture kicked off the exchange and colla... READ MORE |
Genome-wide introgression between two sympatric Asian oak species2022-06-14The genus Quercus, commonly known as oaks, is one of the most evolutionary successful genera in the Northern Hemisphere in terms of species diversity, biomass and distribution range. Oaks can usually live up to a few hundred years and during the long lifespan they exhibit high tolerance to various abiotic and biotic threats. Meanwhile, oaks are also well known for their extensive interspecific gen... READ MORE |
DAV regimen breaks remission records in AML2022-06-11Acute myeloid leukaemia (AML) is the most common leukaemia in adults and accounts for about 80% of all cases. DA regimen is the standard induction regimen for adult AML, consisting of daunorubicin and cytarabine, also known as the 3+7 regimen. However, only 60–80% patients with acute myeloid leukaemia achieve complete remission with the DA regimen and long-term (5-year) overall survival in adults ... READ MORE |
First International Competition on Modern Bamboo Structure Building Design rounds off: ZJUI freshmen cut a striking figure!2022-06-10The First International Competition on Modern Bamboo Structure Building Design rounded off on May 13th. The ZJUI team, composed of freshmen LI Xinyang, YU Yingying, LE Zhiyuan, and CUI Xiaotong and DONG Siyi (21’, Civil Engineering), clinched the Innovative Design Award with their project “Loft without Autumn”.As part of Z4G, Zhejiang University’s sustainability action plan in respon... READ MORE |
Scientists discover inter-generational “memory” mechanism of diabetes2022-06-09Symptomatic treatment was commonly used for chronic diseases in the past. For example, diabetes was often treated by controlling the increase of glucose and alleviating various diabetes-induced complications with insulin. However, how to prevent diabetes has remained elusive in the scientific and medical community, and it has become a global research hotspot to find out the origin of the disease f... READ MORE |
Dialogue@ZJU: With LI Zirui from College of Energy Engineering2022-05-31[Message from the editor: LI Zirui, a doctoral student from College of Energy Engineering, is one of the recipients of the 12th “Top Ten Students” of Zhejiang University. Insightful, inventive and industrious, LI strives on his way to a scientist with the commitment to realizing a blueprint with “zero-carbon buildings”. In this dialogue, we will learn more about his growth trajectory as a... READ MORE |
Conferral of the bachelor degree for the ZJUI Class of 20222022-05-31On the morning of May 29, Zhejiang University-University of Illinois at Urbana-Champaign Institute (ZJUI) held a grand ceremony to confer upon the graduating Class of 2022 their degrees on the Haining International Campus of Zhejiang University.Prof. WU Zhaohui, president of Zhejiang University, and Prof. Robert J. Jones, chancellor of the University of Illinois at Urbana-Champaign, del... READ MORE |
Polypeptide-forming 3D culture developed to expand rare human circulating hematopoietic stem/progenitor cells in steady-state blood2022-05-31Most cells in steady-state peripheral blood (PB) are lineage mature cells, which are differentiated from hematopoietic stem/progenitor cells (HSPCs) residing in the bone marrow (BM) niche. HSPCs are rare in number and hold self-renewal and multi-lineage differentiation potential, regulating the balance and function of various hematopoietic cell subsets in the blood system. Decades of effort have l... READ MORE |